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Chemical exposure and hearing loss☆
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Introduction
Workers are commonly exposed to multiple factors and substances that are hazardous to 
health. For instance, in 2005, approximately 30% of the European workers reported being 
exposed to noise during at least a quarter of the time spent in their work environment, 11% 
reported inhaling vapors such as solvents and thinners; 19% reported exposure to smoke, 
fumes, powder, or dust; and 14% reported handling chemical substances.1 Although 
occupational noise exposure has long been recognized in the United States and in Europe as 
the most deleterious factor to hearing2,3 the impact of chemical-induced hearing loss on 
workers should not be underestimated.4 A cursory survey of the literature for the last three 
decades reveals that concern about the effects of chemicals on hearing has grown steadily. 
The proliferation of work-related substances and medicinal drugs (mostly antitumor drugs 
and aminoglycosides) has been accompanied by an equivalent increase in the number of 
scientific publications on the hearing risks encountered by chemical-exposed persons. Cause 
for concern is even greater when the synergistic risks of co-exposures are considered. For 
example, physiological factors may increase the severity of a chemical’s effect on hearing. 
Today, robust evidence also confirms that the effects of ototoxic substances on ear function 
can be aggravated by noise, which remains a well-recognized cause of hearing impairment. 
In an expert forecast supervised by the European Agency for Safety and Health at Work5 
(EU-OSHA, 2009), a “combined exposure to noise and ototoxic substances” was rated as an 
emerging risk.
Industrial ototoxic chemicals have predominantly been assessed through animal studies, 
which are supported by data from epidemiologic studies on human workers from various 
industries. Bergström and Nyström (1986) published the seminal results of a 20-year 
longitudinal study performed with 319 Swedish employees from different industrial 
sectors.2 This study began in 1958 and involved testing workers’ hearing regularly. Its 
findings showed that a large proportion (23%) of the employees working in a chemical 
division suffered from hearing impairment, despite their exposure to lower noise levels than 
other divisions. Based on this type of evidence, researchers have long hypothesized that 
industrial solvents pose an additive risk to hearing. Scientific findings in animals are 
generally considered qualitatively relevant to human health, provided no substantial 
difference in biological response (e.g. metabolism) exists between test animals and humans. 
Despite these findings, current research is limited by the following:
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1. a lack of detailed exposure histories;
2. the presence of confounding factors (ototoxic drugs, tobacco, alcohol consumption, 
aging, and exposures outside the workplace);
3. and the fact that chemical exposure scenarios used in experimental investigations 
are qualitatively different from real-world occupational settings.
In this extensive, but not exhaustive, review of the literature, the authors hope to share the 
evidence indicating that noise is not the only source of work-related hearing damage and to 
draw greater attention to the matter of chemically induced hearing loss. The present 
publication intends to provide occupational physicians and other health professionals with a 
clear picture of what is known about how chemical substances may affect hearing ability in 
the general population, and more specifically, in workers. The article describes the 
following:
1. chemicals that can be noxious to the inner ear;
2. work areas where exposure to ototoxic substances are likely;
3. and the basic features of the physiological mechanisms leading to hearing 
impairment.
This article also addresses the limitations of pure-tone air-conduction audiometry when 
assessing chemical-induced hearing loss and proposes a more complete approach to evaluate 
the auditory neurosensory hearing receptor and the neural pathways involved in the stapedial 
reflex. With the proposed battery of tests, physicians will be able to evaluate both 
ototoxicity and neurotoxicity. Throughout this manuscript, emphasis is placed on the need 
for stronger links between primary care and occupational physicians. This could help 
preserve patients’ hearing status as a part of their overall health.
Ototoxic drugs
It is well documented that some medicinal drugs, such as powerful antibiotics and anti-
neoplastic drugs used against life-threatening diseases can cause auditory and/or vestibular 
dysfunction in patients. Functional damage can include permanent hearing loss and tinnitus. 
In several countries, administration of these drugs is monitored, and guidelines are available 
online (AAA, 2009, available online at http://www.audiology.org/resources/
documentlibrary/Pages/OtotoxicityMonitoring.aspx). A brief review of these substances is 
presented in the section Which substances can be considered ototoxic?, but first we review 
some of the terms used to describe how they affect hearing and their definitions.
Definitions
Noise is a physical factor that causes mostly mechanical and metabolic damage to the 
peripheral auditory receptor, the cochlea, and more rarely, to the auditory neural 
pathways.6–8 In contrast, chemicals in the bloodstream go through either the blood-labyrinth 
barrier into the cochlea or the blood–brain barrier to reach the eighth cranial nerve and the 
central nervous system.9–13 As a result, chemical-induced hearing loss can be the result of 
effects on several sites within the hearing system. Ototoxic chemicals may affect the 
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structures and/or the function of the inner ear (auditory and vestibular apparatus) and the 
connected neural pathways. From a general point of view, both cochleotoxicants and 
vestibulotoxicants can be defined as ototoxicants.
A cochleotoxicant can affect different cochlear structures, including the auditory sensory 
cells (“hair cells”), the fluid-producing cell layer on the outer wall of the cochlear duct 
(“stria vascularis”), and the spiral ganglion cells. In most cases, cochlear hair cells are the 
primary targets of cochleotoxicants (Figs. 1–5).
Which substances can be considered ototoxic?
This article only reviews chemicals for which the strongest evidence of ototoxicity exists. A 
substance was included if human data are available, or if two well-documented animal 
studies reported clear and reliable findings in a coherent manner. If supporting human data 
were lacking, species-specific features should not contradict extrapolation of animal findings 
to humans. For the sake of clarity, data on potentially ototoxic substances are not reported in 
the present article.
Aminoglycosides—The aminoglycosides, such as streptomycin, kanamycin, neomycin, 
gentamicin, tobramycin, amikacin, and netilmicin are commonly used to treat gram-negative 
bacterial infections. Unfortunately, the clinical benefits of these agents can be outweighed 
by their toxicity, which includes cochlear damage. The incidence of hearing loss ranges 
from a few percent to up to 33% of the aminoglycoside-treated patients. Aminoglycoside-
induced hearing loss spreads from high to low frequencies depending on the duration of 
treatment and the dose. After systemic administration, the antibiotics rapidly go through the 
blood–labyrinth barrier at the level of the stria vascularis to penetrate the cochlea. The drug 
reaches the perilymph and thereby the outer hair cells, which are particularly sensitive to 
antibiotics.14–17 They can remain in the cochlea for several months after discontinuing the 
treatment.18,19 Because of this long clearance time from the inner-ear liquids, occupational 
physicians must take aminoglycoside treatment into account as, after hospitalization, an 
employee could return to work with aminoglycoside-contaminated cochlea, which would 
make them particularly vulnerable to noise. An innocuous noise exposure can become 
noxious with aminoglycosides.20 Consequently, good communication between primary care 
and occupational physicians is required to avoid dangerous co-exposures to noise and 
aminoglycosides. Before their return to work, the company physician should examine 
anyone who has been hospitalized, or anyone who was treated with antibiotics to determine 
the nature of the drugs. Unfortunately, monitoring the serum aminoglycoside level is not 
sufficient to prevent a likely co-exposure since these antibiotics take longer to clear from the 
perilymph (inner-ear liquids) than from the blood. A safer approach would be to protect 
employees from an unexpected co-exposure to noise and aminoglycosides for at least 3 
months after the end of the treatment.
Mechanism of aminoglycoside ototoxicity—Aminoglycosides penetrate the outer 
hair cells from the endolymph. They do not cause lipid peroxidation by themselves; 
however, they form an aminoglycoside–iron complex that interacts with 
polyphosphoinositides. This reaction increases membrane permeability and generates the 
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release of reactive oxygen species (ROS) through the oxidation of arachidonic acid 
(breakdown products) in membranes. Superoxide, hydroxyl radical, and hydrogen peroxide 
then activate the c-Jun N-terminal kinase (JNK) pathway, which can translocate to the 
nucleus to activate genes involved in the cell death pathway. The products of these genes 
translocate to the mitochondria, where they induce the release of cytochrome c, which 
triggers apoptosis via caspases. Cell death may also result from caspase-independent 
mechanisms.21
Anti-neoplastic drugs—Platinum-derivates such as cisplatin and carboplatin are 
anticancer drugs that have ototoxic side effects.22–24 The ototoxicity induced by platinum-
derivates is characterized by the loss of cochlear hair cells and cells of the spiral ganglion 
and by degeneration of the stria vascularis.25 As with aminoglycosides, hearing impairment 
induced by platinum-derivates covers the range from high to low frequencies.26 An 
exacerbation of cisplatin ototoxicity was observed with exposure to concomitant moderate to 
high noise levels in chinchilla and guinea pigs.27,28
Loop diuretics—Ethacrynic acid, furosemide, and bumetanide are three loop diuretics 
widely used to increase the volume of urine excretion as part of the treatment for high blood 
pressure and swelling due to congestive heart failure. They act on the ascending limb of the 
loop of Henle, inhibiting sodium- and chloride-ion reabsorption in the kidney. In the mean 
time, diuretics act on the sodium- and potassium-transporters/pumps located within the stria 
vascularis, disturbing the ionic concentration of endolymph. Therefore, there is a parallel 
effect of diuretics on kidney and ear. Hearing loss is a temporary side effect that lasts only 
during the treatment. The effect is characterized by a sudden high-frequency hearing loss 
due to dysfunctions of the stria vascularis. These dysfunctions affect the ionic gradients 
between the endolymph and the perilymph, decreasing endocochlear potential and thereby 
sensorial transduction.29–31
Toxic interactions of loop diuretics and other known ototoxic drugs have been well 
documented, particularly with aminoglycosides. Dysfunctions at the level of the stria 
vascularis may result in a massive entry of aminoglycosides into the inner-ear fluid.32 Thus, 
the effect of loop diuretics on the stria vascularis facilitates the toxic effects of 
aminoglycosides on the hair cells. Similarly, ethacrynic acid is known to interact with 
cisplatin to increase its ototoxic effects.33 Finally, results from a study in rats showed that 
the ototoxic effect of cadmium may be potentiated by furosemide.34
Acetyl salicylic acid—High doses of acetyl salicylic acid (aspirin;>2.5 g/day) may 
induce a temporary auditory threshold shift and sometimes tinnitus.35,36 In general, recovery 
of normal auditory sensitivity occurs within 2 or 3 days of discontinuing salicylate 
administration. The exact mechanism of salicylate-induced hearing impairments remains 
incompletely known. The ototoxic effects seem to result from a combination of several 
reversible cochlear disturbances.37 Like aspirin, many other painkillers and antipyretics 
(quinine and chloroquine) are recognized for their potential ototoxic side effects. Salicylate-
induced temporary threshold shifts may exacerbate the temporary effects of noise, hamper 
speech discrimination, and increase difficulty in detecting an alarm sounding in a noisy 
environment.38,39
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In many industries workers are exposed to both noise and chemicals, these include printing, 
painting, boat building, construction, glue manufacturing, metal products, chemicals, 
petroleum, leather products, furniture making, agriculture, and mining.1 In addition, some 
public safety workers, like firefighters, are also exposed to both noise and chemicals. 
Environmental exposure studies have determined the concentration of combustion products 
and various toxic agents in the smoke to which firefighters may be exposed.40–44 According 
to these studies, smoke contains numerous harmful chemicals such as acrolein, benzene, 
methylene chloride, polyaromatic hydrocarbons, perchloroethylene, carbon monoxide, 
toluene, trichloroethylene, trichlorophenol, xylene, and formaldehyde. In addition, 
combustion products include metals such as lead, cadmium, mercury, and arsenic. Common 
sources of these metals in structural and vehicle fires include lead (old paint and PVC), 
cadmium (batteries and PVC), mercury (thermostats, automotive switches and 
thermometers), and arsenic (pressure-treated wood).45,46 Many of the compounds detected 
in smoke from fires are also known to be neurotoxic or ototoxic.
Aromatic solvents
Toluene and styrene are the most widely and extensively used aromatic solvents in 
industry.47 Toluene is a major component of adhesives, paints, lacquers, varnishes, printing 
inks, degreasers, fuel additives, glues and thinners, whereas styrene is present when 
manufacturing plastics, rubber articles, and glass fibers.48
Chronic exposure to these aromatic solvents can affect the central nervous system49,50,11 
and also the inner ear.51,52 The cochleotoxic effects of aromatic solvents such as toluene, 
styrene, ethylbenzene, p-xylene, various methylstyrenes, allylbenzene, and n-propylbenzene 
have been repeatedly demonstrated in animal experiments.53–57 Long-duration exposures to 
aromatic solvents have been shown to cause irreversible hearing impairment, with the 
cochlear hair cells as the first targets.58,59 Most of these animal studies were performed with 
rats, whose cochleae are sensitive to aromatic solvents.60,61 Because of their similar 
metabolism, rats are considered comparatively good animal models for investigating the 
potential ototoxic properties of aromatic solvents in humans.62
Mechanisms of aromatic solvent ototoxicity—Aromatic solvents most likely affect 
hearing through chemical poisoning of hair cells, resulting in disorganization of their 
membranous structures.54 An acute effect may be caused by the direct action of solvents on 
the cells of the organ of Corti, whereas chronic ototoxic effects may be explained by the 
formation of chemically and biologically reactive intermediates. These intermediates include 
reactive oxygen species, which may trigger the death of these cells.63 They can also provoke 
dysfunctions of transmembrane K+ fluxes, which play a determining role in the physiology 
of hair cells during acoustic stimulation.64 During acoustic stimulation, K+ enters massively 
into the hair cells; efflux of this K+ from the hair cells into the outer tunnel of the organ of 
Corti increases the ionic level in the extracellular fluid. If this K+ is allowed to accumulate 
in the tunnel fluid, it would cause outer hair cell cytotoxicity. Clearly, K+ recycling from the 
organ of Corti back to the endolymph or to the stria vascularis plays an important role, 
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preventing an adverse local effect on the hair cells and allowing K+ ions to be saved.65 
Solvents transit from the outer sulcus into the organ of Corti, where they likely disrupt the 
role played by the Hensen and Tectal cells, thereby affecting K+ recycling.
Neuropharmacological effects of solvents—Nearly a century ago, volatile chemicals 
were thought to produce non-specific effects on the central nervous system (CNS). More 
recently, clear evidence has emerged regarding how inhaled solvents act specifically on 
several types of ion channels expressed in neurons.66 Many abused inhalants such as toluene 
may enhance inhibitory synaptic responses through their action on specific sites or through 
similar mechanisms of action to other CNS depressants, like anesthetics.67,68 For instance, 
N-methyl-D-aspartic acid,69 δ-aminobutyric acid, glycine,70 adenosyl triphosphate,71 
serotonin,72 and nicotinic acetylcholine receptors73 are all involved in CNS function and are 
sensitive to toluene. Recently, Lataye et al.74 and Maguin et al.75 showed that toluene could 
alter acetylcholine receptors and voltage-dependent Ca2+ channels function in in vivo 
studies. Consequently, toluene, like most aromatic solvents, can affect the middle-ear 
acoustic reflex (the contraction of the middle-ear muscles that occurs in response to high-
intensity sound stimuli). This reflex is driven by a cholinergic efferent system.76 This type 
of effect suggests that the hearing loss observed in solvent-exposed subjects might be due to 
dysfunctions beyond the peripheral auditory system, which could at least partially explain 
the synergistic effects of co-exposure to noise and aromatic solvents.
Co-exposure
What is the evidence from animal experiments?: Experiments with rats have shown that 
combined exposure to noise and solvents (such as toluene, styrene, and ethylbenzene) 
induces synergistic adverse effects on hearing.77–81 In most of these investigations, high 
concentrations of solvents were used for short intervals of time, conditions which do not 
accurately reflect occupational exposure conditions.
Another difficulty with recreating real-life conditions stems from the fact that humans are 
generally exposed to solvents in combination with a multitude of other factors (several 
exposures, physical demands, etc.); whereas animal experiments typically involve isolated 
solvent exposures. In studies with experimental animals, researchers have demonstrated that 
when other stressors are added (such as impact noise or carbon monoxide), or when the 
animals are active during the chemical exposure, the lowest concentration at which solvents 
elicited an auditory effect was reduced.79 Another complication in determining the 
concentration needed for hearing loss is that workers are often not aware of the 
concentration to which they are exposed, and many factors can interact to cause effect. 
However, cases of hearing loss have been observed after exposures that were within 
permissible European limits, these will be detailed in the next session.
Lataye et al.79 found interactive effects of noise and styrene with quite low levels of noise: 
A time-weighted average (TWA) of 85 dB and low concentration of styrene: 400 ppm, 6 h 
per day, 5 days per week for 4 weeks. In this investigation, solvent absorption was increased 
by forcing animals to walk in a special wheel during the exposure; as this reflects more 
closely human exposure scenarios where subjects are rarely stationary.
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Recently, it has been reported that some aromatic solvents reduce the protective role played 
by the middle-ear acoustic reflex.76 A dysfunction of this reflex would increase risks to 
hearing by allowing higher acoustic energy levels to penetrate the inner ear.75,82 This would 
make co-exposure more dangerous than exposure to noise or to styrene alone.
What is the evidence from epidemiological studies?: In general, clinical or 
epidemiological studies are designed to test hypotheses, such as the hypothesis that certain 
chemicals are ototoxic. Several clinical and epidemiological studies confirmed an 
association between exposure to solvents (styrene, toluene, xylenes, solvent mixtures, and 
jet fuels) in the workplace and increased prevalence of hearing loss, as well as poor hearing 
thresholds beyond the traditional 4 kHz noise-related audiometric notch.83–92 For an 
extensive review of human studies, see Johnson and Morata93 (available online at https://
gupea.ub.gu.se/handle/2077/23240).
To examine dose–response relationships, large populations and detailed exposure 
information would be needed, which can be very challenging to obtain. Thus, the limitations 
of existing studies (e.g., study designs, insufficient characterization of the exposure levels 
for chemicals and noise, and lack of details on whether and how other risk factors were 
accounted for) do not allow us to identify the following: (1) the type of interaction between 
the agents and how their results can be used to estimate dose–response relationships or (2) 
the lowest concentrations necessary for an effect to be detected for the solvents covered in 
the present document. Overall, studies conducted with experimental animals provide the 
most robust evidence regarding mechanisms and dose–effect relationships between agents 
and effects on the auditory function or physiology.
Given the difficulties of extrapolating animal findings and analyzing the data obtained from 
human studies, those in charge of prevention policy must consider both experimental and 
epidemiological studies.
The approaches adopted in different countries have been described in two recent reviews.5,93 
Overall, with combined exposure to noise and organic solvents, interactive effects may be 
observed depending on the parameters of noise (intensity and impulsiveness) and the 
solvent-exposure concentrations. In case of concomitant exposures, solvents can exacerbate 
noise-induced impairments even with a noise intensity below the European permissible limit 
value.
From a mechanistic point of view, solvent-induced hearing impairment in humans would 
suggest the involvement of both the inner ear and the central nervous system.
Non-aromatic solvents
What do animal experiments show?
Trichloroethylene is a cleaning and degreasing agent that can also be used for extractions in 
different chemical processes. Exposure to high concentrations of trichloroethylene has been 
shown to disrupt cochlear sensory hair and spiral ganglion cells as well the auditory nerve 
pathways within the cochlea.94–98
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In contrast, carbon disulfide (used as a solvent for lipids, sulfur, rubber, phosphorus, oils, 
resins and waxes), as well as n-hexane (used as a cleaning agent for textiles, furniture, and 
leather) have been shown to affect the auditory nervous pathway beyond the cochlea in 
animals99–103; for review see Vyskocil et al.104 These two solvents are associated with 
retrocochlear dysfunctions.
Nitriles
Nitriles are mainly used for the preparative synthesis of carboxylic acids. However, 
acetonitrile is used as a solvent, benzonitrile as an initial compound for melamine resins, and 
acrylonitrile as a monomer for polyacrylonitrile. The ototoxic effects of these compounds 
have been demonstrated in animal experiments only. Cis-2-pentenenitrile, 3-butenenitrile, 
cis-crotononitrile, and 3,3′-iminodipropionitrile were shown to cause cochlear hair cell 
losses and spiral ganglion cell losses, respectively, in rats, mice, guinea pigs, and 
frogs.13,105,53 In contrast, acute exposure to acrylonitrile in rats produces a transient 
reduction in auditory sensitivity in the high-frequency range.106
After administration of acrylonitrile, noise-induced hearing impairment was significantly 
potentiated in rats.106 Under test conditions in which neither acrylonitrile nor noise 
exposures caused any permanent hearing loss, combined exposure caused permanent hearing 
impairment and significant losses of the outer hair cells. Thus, hearing loss may occur at low 
noise intensities if simultaneous exposure to acrylonitrile occurs. Pouyatos et al.107 
hypothesized that acrylonitrile increases the risk of noise-induced oxidative damage to the 
inner ear by impairing the antioxidant’s defense mechanisms of the cells.
Asphyxiants
Carbon monoxide and hydrogen cyanide (salts: cyanides) are two well-known ototoxic 
asphyxiants. The first is found in exhaust fumes when combustion processes are incomplete 
in motor vehicles, poorly ventilated stoves and furnaces, acetylene welding, or in enclosed 
areas (mines and tunnels). Hydrogen cyanide is used as an intermediate product in the 
organic synthesis of carboxylic acids, pharmaceuticals, dyes and pesticides; relatively large 
quantities are also required for the surface treatment of metals, galvanizing, and the cyanide 
leaching process.
What do animal experiments show?—The ototoxicity of asphyxiants is believed to be 
a consequence of effective oxygen deprivation (hypoxia) within the cochlea. In animal 
experiments, exposure to carbon monoxide or cyanide has reversible auditory effects at low 
concentrations and impairs cochlear function under severe exposure conditions.108–110 
These experimental studies showed that the two asphyxiants predominantly affect hearing 
for high-frequency tones, and suggested that while cyanides induce dysfunction of the stria 
vascularis,110 carbon monoxide produces excessive glutamate release (glutamatergic 
excitotoxicity) in the synaptic area below the inner hair cells.111
Both carbon monoxide and cyanides have been found to potentiate permanent noise-induced 
hearing loss in animals and humans.106,112–118 This potentiation may be the result of a 
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reduction in the cell’s ability to repair noise-induced damage due to carbon monoxide 
poisoning.112,113
What do epidemiological studies show?—In a large epidemiological investigation 
conducted by Lacerda et al.,118 the hearing thresholds of employees working in noisy 
occupational environments with combined carbon monoxide exposures were compared with 
the hearing thresholds of employees working in noisy occupational environments without 
carbon monoxide. The analysis was based on 9396 audiograms collected by the Quebec 
National Public Health Institute between 1983 and 1996. The results showed significantly 
higher hearing thresholds at high frequencies (3, 4 and 6 kHz) for the carbon monoxide-
exposed group, with more pronounced effects observed as the duration of exposure 
increased (15–20 years of exposure).
For an extensive review of human studies with carbon monoxide using other designs, see 
Johnson and Morata.93 Even though further human studies are needed to clarify these 
findings, noise-induced hearing impairment also appears to be potentiated by carbon 
monoxide in humans.
Tobacco smoke—Although a few studies have found no association between smoking 
and hearing impairment,119,120 numerous epidemiological studies suggest a link.121–126 
Tobacco smoke contains hydrogen cyanide among other compounds, and results from 
epidemiological investigations indicate that smokers may have an increased risk of noise-
induced hearing impairment.121,127
Metals and metal compounds
Lead and mercury—Lead and mercury are metal compounds that are known to be 
neurotoxic, and therefore ototoxic.128,129 Lead and lead compounds can be found in the 
manufacture of lead–acid batteries and plastic, in ship breaking, in paint and petrol. Lead 
may also be present during car radiator repair, welding, plumbing, smelting, refining, and 
mining. Mercury can be found in the chlorine–alkali (chloralkali) industry; the industrial 
process is performed in mercury cells in which mercury acts as the cathode to produce 
chlorine and sodium hydroxide. Like lead, mercury compounds may be used in batteries 
(mercuric oxide) and found in pigments, catalysts, explosives (mercury fulminate), 
laboratory-based research, and in some pharmaceutical applications.
Several studies carried out with monkeys exposed long-term to lead, and epidemiological 
studies on lead-exposed workers suggest that lead has an ototoxic effect caused by a 
neurotoxic mechanism.130–134 Similarly, mercury compounds were shown to induce 
hearing-damaging effects both in laboratory animals (methyl mercury chloride and mercuric 
sulfide) and humans.135–138
A few studies did not confirm the effect of these metals on hearing,139,140 but, given the 
current evidence from human studies, lead and mercury do appear to be ototoxic.
Tin and organic compounds—Tri-n-alkyltins are phytotoxic agents used as powerful 
bactericides and fungicides. Trimethyltin and triethyltin induce hearing impairments in both 
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rats and guinea pigs, the severity of which is dose-dependent.141–145 Acute limbic-cerebellar 
syndrome, which includes hearing impairment and involuntary eye movements (nystagmus), 
was detected in six industrial workers who inhaled trimethyltin.146
Germanium and manganese—Germanium and manganese are found in the 
manufacture of steel alloys, dry-cell batteries, electrical coils, ceramics, matches, glass, 
dyes, in fertilizers, welding rods, as oxidizing agents, and as animal food additives.
The administration per os of germanium dioxide (100 mg/kg/day for 4 weeks and 0.5% in 
food for 2 months) provoked hearing impairment in rats and guinea pigs due to degeneration 
of the stria vascularis and the cochlear supporting cells.147 Other authors assessed alterations 
of brainstem transmissions in similar tests.148
Nikolov149 reported in 1974 that the potential ototoxicity of manganese may be exacerbated 
by exposure to noise, and that workers exposed to both manganese and noise seemed to have 
accelerated hearing impairment compared with those exposed to manganese alone.
Halogenated hydrocarbons
Finally, there is a strong suspicion for an ototoxic potential of cadmium and arsenic 
compounds, as well as halogenated hydrocarbons [polychlorinated biphenyls (PCB), 
tetrabromobisphenol A, hexabromocyclododecane and hexachlorobenzene].150–152 Animal 
data suggest that halogenated hydrocarbon-induced hearing impairments are the sequelae of 
thyroid gland disorders caused by some of these substances.153,154 In addition, Powers et 
al.155 proposed in 2006 that polychlorinated biphenyls could have a direct adverse effect on 
the outer hair cell function.
Chemical intoxication and presbycusis
Presbycusis refers to a constellation of age-related physiological degenerations, causing a 
bilateral loss of hearing sensitivity ranging from high to low audiometric frequencies and a 
decreased ability to understand speech, particularly in the presence of background 
noise.156–158 From a histopathological point of view, four predominant types of presbycusis 
can be identified159:
• Sensory presbycusis, which refers to the loss of sensory hair cells and supporting 
cells in the cochlea.
• Neural presbycusis, which refers to degeneration of nerve fibers (Fig. 2) in the 
cochlea and central neural pathways. A large decrease occurs in the density of 
spiral ganglion cells and afferent fibers, especially evident in the apical turn of the 
spiral ganglion (Fig. 6, bottom panels).
• Strial presbycusis, which results from degeneration of the stria vascularis in the 
cochlea. Strial presbycusis is characterized by vascular stenosis and reduced 
vascularization.
• Mechanical presbycusis, which results from morphological changes of the basilar 
membrane of the cochlea.
Campo et al. Page 10













At younger ages (<50 years), the first effects of presbycusis are normally concealed by 
central counterbalancing mechanisms. Indeed, after an acoustic trauma or an ototoxic 
intoxication, the central nervous system can increase the spontaneous firing rate of neurons 
in the dorsal cochlear nucleus160,161 or decrease gabanergic inhibition in the inferior 
colliculus.162,163 This neural hyperactivity maintains a suitable level of excitability of the 
auditory nerve cells: the phenomena are called “up-regulation” in the dorsal cochlear 
nucleus and “down-regulation” in the inferior colliculus. In addition to these up- and down-
regulations within the auditory central nuclei, younger subjects have more cochlear hair cells 
than necessary for assuring normal hearing. As a result, a limited loss of hair cells can be 
sustained without leading to significant hearing deficits.164 For all these reasons, the effects 
of ototoxic substances in an exposed population cannot be fully determined by pure-tone 
audiology (PTA) alone.
What are the consequences of trauma or poisoning on the first manifestations of 
presbycusis?
Noise exposure (even at moderate intensity) or chemical intoxication can exacerbate age-
related hearing loss and lead to early presbycusis, due to exhaustion of the compensatory 
strategies developed by the different features of the hearing system.165 Like noise, the 
effects of ototoxic agents are insidious and hard to correlate with the duration of exposure. 
Hearing damage is generally identified after several years of exposure when it is too late to 
take preventive action. An early diagnosis of presbycusis is definitely an admission of 
failure. Preventive action must be taken when it is still possible to preserve workers’ 
hearing. As a result, we believe PTA is not the appropriate test to use for auditory follow-up 
when people are exposed to noise or ototoxic agents.
Although many people experience a decrease in hearing acuity with age, others do not, and 
it is not possible to predict who will and who will not develop hearing loss as they get older. 
The median hearing loss attributable to aging for a given age group cannot be generalized to 
all individuals in that age group. Thus, when calculating significant threshold shifts, age-
correcting hearing thresholds will overestimate the expected hearing loss for some people 
and underestimate it for others.
The adjustment of audiometric thresholds to account for age-related effects has become a 
common practice in workers’ compensation litigation. The age-correction of audiograms 
measured as part of an occupational hearing loss prevention program is not 
recommended.166
Patient evaluation, diagnosis, prevention and treatment
Today, few health care providers inquire about hearing loss. In fact, among older adults, 60 
years of age and older, only 15% of the primary care providers asked or screened patients 
for hearing loss.167 If hearing loss is rarely addressed among older adults, for whom many 
providers would expect hearing loss to be an issue, even fewer clinicians are likely to 
inquire about hearing loss and tinnitus among middle-aged persons who are exposed to 
ototoxic substance and/or loud noise in the work or home environment (hearing risks are not 
confined solely to workplace noise or chemical exposures). Each case history should 
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investigate risk factors in all aspects of the subject’s daily activities, including occupational 
and nonoccupational tasks, and be followed by appropriate referral and/or counseling. In 
addition, if hearing is found to be impaired (regardless of etiology), this should not dissuade 
the physician from encouraging the patient to protect their residual hearing. Each 
consultation offers a chance for education that should not be wasted. Subjects who are at 
risk of hearing loss and tinnitus due to exposure to ototoxic substances and noise need to be 
fully informed about the risks they run and the protection strategies that can be 
implemented. They must assume responsibility for using personal protective equipment, and 
develop the habit of using it whenever they are exposed to loud noise (both on and off the 
job). Thus it is important for health professionals to make a point of seeking out risks to 
patients’ hearing and advising them appropriately. Many resources are available to help 
guide counseling activities, including online materials from professional organizations, 
advocacy groups, government agencies, and vendors of hearing-related health products. 
However, as the accuracy of information varies greatly among online resources a critical 
review should be undertaken before using the information.
Evaluation and diagnosis
Dysfunctions of the central auditory nervous system following occupational exposures have 
been described on the basis of results from behavioral tests, despite some studies reporting 
normal hearing thresholds.168–173 This suggests that hearing loss caused by chemicals can 
affect a worker’s life more extensively than noise-induced hearing loss, because sounds are 
perceived not only as less loud, but also as distorted. Word recognition may also be 
compromised.
While pure-tone air-conduction audiometry (PTA) remains the most commonly used clinical 
test both in the United States and Europe to measure the extent of temporary and permanent 
hearing loss, it has been shown to be insufficient for examining hearing loss from mixed 
exposure to noise and ototoxic agents, because it does not allow the source of the problem to 
be diagnosed (i.e., cochlear vs. retrocochlear). In the case of central hearing loss, a PTA can 
indicate normal hearing, but a person can still have difficulty understanding speech, 
particularly in background noise, making it difficult to hold a conversation in a busy 
restaurant or at a party. Thus, for persons exposed to ototoxic chemicals in isolation or in 
combination with noise it is important to use tests that evaluate the auditory system more 
comprehensively, from the cochlea to the higher auditory pathways. These tests may help 
differentiate between the individual (or the combined) effects of noise and ototoxicants on 
hearing.
As a result, PTA should be complemented with supplementary prevention tools such as 
distortion product otoacoustic emissions (DPOAEs). Cubic DPOAEs detect inner-ear 
dysfunctions only, particularly those involving the outer hair cells sensitive to noise and 
ototoxicants. The inclusion of DPOAEs in a battery of tests to assess hearing would 
facilitate the distinction between sensory and neural hearing disorders. By combining 
DPOAE measurements with contra-lateral acoustic stimulation, the stapedial reflex can also 
be measured. This is important as ototoxicants were recently shown to affect the central 
nuclei driving the middle-ear acoustic reflex.76,82 Therefore, from a safety point of view, it 
Campo et al. Page 12













would be more efficient to collect and measure performances both in the middle ear and in 
the inner ear. The acoustic reflex would allow chemically induced retrocochlear disorders to 
be evaluated. Equipment is being designed to offer an alternative to subjective PTA to detect 
early-stage hearing impairment. One example is the EchoScan, which can provide sensitive, 
objective, quick, and reliable measurements of both inner- and middle-ear performances, 
taking both the age and gender of subjects into account.174 This system does not require 
stringent acoustic conditions (it does not have to be carried out in a sound-proof booth, it can 
be carried out in a quiet room), making it very convenient for use in the workplace. It is 
therefore suitable for occupational medicine, especially for the auditory follow-up of people 
exposed to noise and/or ototoxic agents. The major advantage of EchoScan is that it 
facilitates detection of the middle-ear reflex, which is quite sensitive to the 
neuropharmacological effects of some ototoxic substances. As a result, EchoScan can assess 
both the inner-ear (amplitude of the distortion products) and the middle-ear reflex at the end 
of a working day. Fifteen minutes before and after the exposure are enough to go through all 
the tests and to obtain an idea of the cochlear and retrocochlear effects of suspected 
substances. This system is quite promising for early detection of effects in hearing 
conservation programs.
Although ideal, we acknowledge that the routine use of an extensive battery of audiological 
tests in primary care settings may be prohibitive because of time and cost constraints. In the 
face of such constraints, the selection of a minimum battery of tests with proven validity and 
reliability, as well as availability and ease of administration, becomes crucial for planning a 
protocol for routine evaluation.
Prevention
While hearing loss is one of the principal work-related disabilities among various groups of 
workers, a considerable number of losses could be prevented if exposure to known oto-toxic 
chemicals, alone or in combination with even mild to moderate noise, was included in risk 
assessment and management. The initial steps of hearing loss prevention programs are 
hazard assessment and control. It is important to learn whether and which hazardous 
exposures exist in a workplace. Whenever hazardous noise or chemicals exist in the 
workplace, measures to reduce exposure levels to protect exposed workers and to monitor 
the effectiveness of these interventions are required by law. The most effective way to 
prevent hearing loss due to noise or chemical exposure is to remove the source of risk from 
the workplace by engineering controls, finding alternatives to minimize exposure (such as 
reducing the duration of exposure), or requiring the use of personal protective equipment if 
engineering or administrative controls do not eliminate exposure. If the use of personal 
protective equipment is required, it should be worn as directed. Many professional 
organizations and government agencies have comprehensive sources of information to help 
guide your counseling activities.
Conclusions
Evidence of how hearing dysfunctions can be caused by chemicals and the combined effects 
of co-exposures to noise and ototoxic chemicals have emerged predominantly from animal 
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tests in which these associations have been demonstrated. Animal studies have been used to 
assess the specific effects of several substances to be studied in controlled and appropriate 
experimental conditions. These findings are supported by cross-sectional epidemiological 
studies in workers from different industrial sectors exposed to styrene, toluene, solvent 
mixtures, carbon disulfide, or to a combination of noise and solvents such as toluene, 
styrene, and ethylbenzene. The risks encountered by workers exposed to chemicals or to 
chemicals and noise are real, and data obtained from animal models must not be neglected. 
Today, our scientific knowledge is robust enough to recommend at least precautionary 
measures for use in occupational environments where workers are exposed to chemicals.
Recommendations
Recognizing the risk of occupational chemical exposure on hearing, the European noise 
legislation (Directive 2003/10 EC noise)175 as well as the U.S. Army Hearing Conservation 
guidelines already included ototoxic chemical exposure as a risk factor to be considered in 
risk assessment and prevention strategies for hearing. The U.S. Army Center for Health 
Promotion and Preventive Medicine176 also issued a recommendation to consider ototoxic 
chemical exposures for inclusion in a hearing conservation program and to provide annual 
audiograms for workers exposed to these chemicals, particularly in combination with 
marginal noise. The American College of Occupational and Environmental Medicine 
(ACOEM) guidance statement also indicates that exposure to ototoxicants should be 
considered when health professionals evaluate sensorineural hearing loss (ACOEM, 
2012).177
The American Conference of Governmental Industrial Hygienists (ACGIH) stated in its 
Threshold Limited Values® and Biological Exposure Indices® publications that periodic 
audiograms are advised and should be carefully reviewed in occupational settings where 
exposure to toluene, lead, manganese, or n-butyl alcohol occurs.178 But none of these 
require clear hearing controls following exposure to ototoxic substances or to co-exposures 
with noise. In fact, no regulations require workers’ hearing to be monitored when they are 
exposed to ototoxic chemicals. Tests for ototoxicity should be standardized and incorporated 
into national, or even international guidelines. More frequent medical monitoring should be 
considered for workers exposed to ototoxic substances, irrespective of the noise exposure 
level, and workers’ health results should be recorded to allow early changes at individual 
and collective levels to be detected.
The audiological control of workers exposed to noise, chemicals, or both should go further 
than PTA or DPOAE measurements to take the main dimensions of hearing impairments 
into consideration. An assessment of the loss of communication skills, a middle-ear test (a 
quick measure of the stapedial reflex), and questionnaires on therapeutic treatments or 
exposure to chemicals should be included in the battery of audiological tests used to allow 
early detection and correctly evaluate the total effects on workers hearing. This battery of 
tests could also be used as an early indicator of neurotoxicity and would be helpful to 
evaluate the toxicity of industrial chemicals and establish occupational exposure limits.
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Ideally, after hospitalization and before returning to work, employees should be interviewed 
by an occupational physician and potentially ototoxic drugs administered as part of the 
treatment should be listed. Because the precautionary principle of the EU Commission 
requires an adequate level of protection even when scientific data are insufficient or 
ambiguous, individual hearing protectors are recommended for at least 3 months post-
treatment for exposures of 80 dBA and above (time-weighted average) in a complex 
occupational environment (noise plus chemical ototoxic substances). (The precautionary 
principle is based on evidence that is graded as fair and information from one or two studies 
that are judged to be reliable.) A special label for ototoxic substances may be considered for 
chemicals.
For too long, hearing loss prevention has been viewed as a specialized area for a few 
professionals who manage occupational hearing conservation programs. Hearing loss due to 
work-related exposure represents a substantial portion of all hearing impairments. Because 
most work-related hearing losses are permanent, the only way to reduce their burden on 
society is to prevent them. Without intervention, the financial and social costs of hearing 
loss also become significant. Physicians have the tools and the opportunity and are in a 
strategic position to advocate for healthy hearing practices and to facilitate hearing loss 
prevention. The public health nature of work-related hearing loss and the magnitude of the 
problem in today’s society require their increased involvement.
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Cross section of the cochlea. mb, membrane. Left bottom panel: organ of Corti. (Color 
version of the figure is available online.)
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Mechanisms of aminoglycoside-induced outer hair cell damage. AG, aminoglycoside; AG–
Fe, aminoglycoside– iron complex; ROS, reactive oxygen species; JNK, c-Jun N-terminal 
kinase; Cyt C, cytochrome C. Adapted from Rybak and Ramkumar.21
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Mechanisms of anticancer drug toxicity. CP, cisplatin; MHC, monohydrate complex; ROS, 
reactive oxygen species; NOX-3, NADPH oxidase 3; Cyt C, cytochrome C. Adapted from 
Rybak and Ramkumar.21
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Intoxication route for different medicines and work-related substances. (A) Anti-neoplastic 
drugs and aminoglycosides are hydrophilic substances, whereas solvents are lipophilic 
substances. (B) Loop diuretics modify the activity of the ionic pumps, whereas aspirin 
affects blood fluidity within the stria vascularis. As a result, the ionic concentration of 
endolymph is disturbed until the molecules are cleared from the system. (Color version of 
the figure is available online.)
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Scanning electron micrograph of a rat organ of Corti prior to- (A) and post- (B) toluene 
exposure. When present, the stereocilia of the hair cells look normal in both images.
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Neural presbycusis. Mid-modular cut cochlea. The left panels correspond to a 25-month-old 
rat, whereas the right panels correspond to a 5-month-old rat. (Color version of the figure is 
available online.)
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